Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,850,254
-
Share change
-
+45,778
-
Total reported value
-
$1,367,000
-
Price per share
-
$0.74
-
Number of holders
-
19
-
Value change
-
+$33,663
-
Number of buys
-
8
-
Number of sells
-
6
Institutional Holders of TENAX THERAPEUTICS INC - COM (TENX) as of Q2 2017
As of 30 Jun 2017,
TENAX THERAPEUTICS INC - COM (TENX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,850,254 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Bank of New York Mellon Corp, BAKER BROS. ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Virtu KCG Holdings LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, Verition Fund Management LLC, and D.A. DAVIDSON & CO..
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.